|
Volumn 350, Issue 19, 2004, Pages 2001-2003
|
Postmenopausal Osteoporosis and Strontium Ranelate [2] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALUMINUM;
CREATININE;
FLUORIDE;
PLACEBO;
STRONTIUM;
STRONTIUM RANELATE;
TRACE ELEMENT;
UNCLASSIFIED DRUG;
ORGANOMETALLIC COMPOUND;
THIOPHENE DERIVATIVE;
ANIMAL MODEL;
BONE BIOPSY;
BONE MINERALIZATION;
BONE RADIOGRAPHY;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DIALYSIS;
DRUG EFFICACY;
HUMAN;
KIDNEY FAILURE;
KIDNEY FUNCTION;
LETTER;
NONHUMAN;
OSTEOMALACIA;
OSTEOPOROSIS;
POSTMENOPAUSE;
POSTMENOPAUSE OSTEOPOROSIS;
PRIORITY JOURNAL;
PROBABILITY;
RAT;
RISK ASSESSMENT;
VERTEBRA FRACTURE;
FEMALE;
METHODOLOGY;
NOTE;
OUTCOME ASSESSMENT;
PROPORTIONAL HAZARDS MODEL;
STATISTICAL ANALYSIS;
SURVIVAL;
BONE DENSITY;
BONE REMODELING;
CHEMICALLY INDUCED DISORDER;
DRUG EFFECT;
SPINE FRACTURE;
DATA INTERPRETATION, STATISTICAL;
FEMALE;
HUMANS;
ORGANOMETALLIC COMPOUNDS;
OSTEOPOROSIS, POSTMENOPAUSAL;
OUTCOME ASSESSMENT (HEALTH CARE);
PROPORTIONAL HAZARDS MODELS;
SURVIVAL ANALYSIS;
THIOPHENES;
BONE DENSITY;
BONE REMODELING;
CALCIFICATION, PHYSIOLOGIC;
OSTEOMALACIA;
SPINAL FRACTURES;
|
EID: 2342457696
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200405063501917 Document Type: Letter |
Times cited : (10)
|
References (0)
|